Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals, Inc. - Common Stock

Share · US00509G2093 · ABOS (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Acumen Pharmaceuticals, Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
7
0
0
0
No Price
29.04.2026 17:43
Current Prices from Acumen Pharmaceuticals, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
IEXG: IEX
IEX
ABOS
USD
29.04.2026 17:43
2,37 USD
-0,09 USD
-3,86 %
XNAS: NASDAQ
NASDAQ
ABOS
USD
29.04.2026 17:27
2,37 USD
-0,09 USD
-3,86 %
Share Float & Liquidity
Free Float 76,52 %
Shares Float 46,35 M
Shares Outstanding 60,57 M
Company Profile for Acumen Pharmaceuticals, Inc. - Common Stock Share
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Company Data

Name Acumen Pharmaceuticals, Inc. - Common Stock
Company Acumen Pharmaceuticals, Inc.
Symbol ABOS
Website https://acumenpharm.com
Primary Exchange XNAS NASDAQ
ISIN US00509G2093
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Daniel J. O'Connell
Market Capitalization 149 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 427 Park Street, 22902 Newton
IPO Date 2021-07-01

Ticker Symbols

Name Symbol
NASDAQ ABOS
More Shares
Investors who hold Acumen Pharmaceuticals, Inc. - Common Stock also have the following shares in their portfolio:
MEINSOLARD. ANL 24/29
MEINSOLARD. ANL 24/29 Bond
NORDASIA.CO
NORDASIA.CO Fund